Sign In
Buy IOVA
$3.79
-0.310 (-7.56%)
At Close: Jun 03, 2026
Royal Bank of Canada Grows Stake in Iovance Biotherapeutics Inc (NASDAQ:IOVA)
06:50am, Tuesday, 07'th Jul 2020
Royal Bank of Canada grew its holdings in Iovance Biotherapeutics Inc (NASDAQ:IOVA) by 219.1% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 107,07
Humanigen Appoints Senior Executives to Management Team
12:00am, Tuesday, 07'th Jul 2020
Humanigen, Inc., (HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating cytokine release syndrome (CRS) w
Five kinds of health appointments you should consider keeping, despite the pandemic
12:59pm, Thursday, 02'nd Jul 2020
Most Americans made a lifestyle U-turn several months ago because of the potential risks posed by the coronavirus pandemic. Activities that once were a given in our day-to-day lives have become less c
Muscle mass may help maintain a strong immune system: Study
02:30pm, Wednesday, 01'st Jul 2020
The study revealed that strong skeletal muscles can play an important role in maintaining an effective immune system.
Is Iovance Biotherapeutics a Buy?
11:11am, Wednesday, 01'st Jul 2020
After rumors swirled about a potential acquisition, it now appears the biopharma is transitioning to commercial operations as a standalone company.
NIH Spearheads Study To Test At-Home Screening For HPV And Cervical Cancer
09:00am, Wednesday, 01'st Jul 2020
The National Cancer Institute plans to launch a multisite study next year involving roughly 5,000 women to assess whether self-sampling at home for the human papillomavirus that causes cervical can…
Fake Coronavirus Antibody Tests: Here's How to Protect Your SSN and Insurance Information
01:20pm, Tuesday, 30'th Jun 2020
Here are important things you should know,
Biovica International AB : – Annual Report for the fiscal year 2019/2020 published | MarketScreener
06:01am, Tuesday, 30'th Jun 2020Experts Identify Steps to Expand and Improve Antibody Tests in COVID-19 Response
04:05am, Tuesday, 30'th Jun 2020
More than 300 scientists and clinicians from the federal government, industry and academia published a report of their conclusions and recommendations on COVID-19 serology studies online in Immunity.
Everbridge, Inc. (NASDAQ: EVBG), the global leader in Critical Event Management (CEM), today announced the company successfully renewed its Federal Ri
Analysts Offer Insights on Healthcare Companies: Zogenix (NASDAQ: ZGNX) and Merck & Company (NYSE: MRK) - Markets
08:11am, Monday, 29'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zogenix (ZGNX
H.C. Wainwright Sticks to Their Buy Rating for Lineage Cell Therapeutics (LCTX) - Markets
10:53am, Sunday, 28'th Jun 2020
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Lineage Cell Therapeutics (LCTX – Research Report) on June 25
CDC: Here Are 3 ‘New’ Covid-19 Coronavirus Symptoms To Make 12
12:00am, Saturday, 27'th Jun 2020
These three symptoms may have been added to the CDC list a while ago.
Incidence of thyroid cancer has doubled globally, analysis finds
03:48pm, Friday, 26'th Jun 2020
The number of people diagnosed with thyroid cancer has more than doubled worldwide since 1990, fueled by a rise in cases in Asia. The United States accounts for 10 percent of cases worldwide.
